Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in TAP Block for Post-Cesarean Pain
NCT03098420Phase 3Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2016
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in Persistent postsurgical pain (PPSP) (3 arms), sponsored by University of Alabama at Birmingham. Primary endpoints: Average Pain Score at 48 hours and Duration of Transversus Abdominal Plane Block at 48 hours. Started Jul 2016; status: terminated.
02
Drugs
dexamethasone
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT03098420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03098420.